2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
4
Pain, Postoperative
3
Spondylitis, Ankylosing
2
Pain
2
Neoplasms
2
Lung Neoplasms
2
Colonic Neoplasms
2
Agnosia
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunction, Physiological
1
Pituitary Neoplasms
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Mucositis
1
Lymphoma, Follicular
1
Inflammation
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Chronic Pain
1
Carcinoma, Non-Small-Cell Lung
1
Arthritis, Rheumatoid
1
Arthritis, Psoriatic
1
Anastomotic Leak
1
Adenocarcinoma of Lung
1
Acute Pain
1
Interventions
Ketamine
4
Surveys and Questionnaires
3
Oxycodone
2
Gabapentin
2
Diclofenac
2
Anesthesia, General
2
Acetaminophen
2
Transcutaneous Electric Nerve Stimulation
1
Tea
1
Ropivacaine
1
Quality of Life
1
Psychotherapy
1
Pregabalin
1
Passive Cutaneous Anaphylaxis
1
Minocycline
1
Meloxicam
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Ibuprofen
1
Hydromorphone
1
Fentanyl
1
Ethyl Chloride
1
Epinephrine
1
Duloxetine Hydrochloride
1
Diathermy
1
Dexmedetomidine
1
Cryotherapy
1
Control Groups
1
Circumcision, Male
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acute Pain
×
Anti-Inflammatory Agents, Non-Steroidal
×
Clear all
NCT01789216
2021-02-03
PAIN
Major Extremity Trauma Research Consortium
Phase 3
Completed
450 enrolled